MetaCap

Prenetics Global Limited Class A (PRE)

NASDAQ: PREFinanceBlank ChecksUSD

8.80-1.51 (-14.65%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PRE stock chart

Technical analysis

Key statistics

All statistics
Market cap
$171.73M
EPS (TTM)
-$3.10
52-week range
8.69 – 27.24
Day range
8.70 – 10.29
Volume / Avg
593.99K / 257.57K
Beta
—

52-week range

$8.69$27.24

PRE stock today

Prenetics Global (PRE) closed at $8.80 on Nov 20, down 14.65% (-$1.51), versus the S&P 500's 3.70% decline. Volume was 2.3x the average at 593.99K shares, a sign of unusually heavy trading. Shares are 67.7% below their 52-week high of $27.24, set on Sep 2, 2026 and 1.3% above the 52-week low of $8.69, near the bottom of the past year's range.

PRE is down 44.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 30.6%. Prenetics Global has posted a net loss over the last twelve months (EPS of -$3.10), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Prenetics Global

Company profile

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories.

Sector
Finance
Industry
Blank Checks
CEO
Mr. Sheng Wu Yeung
Headquarters
Quarry Bay
Employees
98

Financial highlights

Full financials

In fiscal 2024, Prenetics Global generated $30.6 million in revenue, up 40.8% from fiscal 2023, its 3rd consecutive year of revenue growth. Prenetics Global reported a net loss of $46.3 million, compared with a loss of $62.7 million a year earlier. Gross margin was 50.3% (up from 40.6%) and operating margin -157.2%.

Prenetics Global annual revenue, net income and EPS
Fiscal yearFY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$30.62M$21.74M$13.16M$12.53M$65.18M
Growth+40.83%+65.17%+5.04%-80.77%—
Net income$-46.30M$-62.72M$-190.45M$-174.01M$-1.94M
EPS (diluted)$-3.71$-5.58$-37.57$-178.81$-0.15

Analyst forecast

Forecast

Consensus (7 analysts)

strong_buy

Avg. price target

$38.44+336.82%

  • Strong buy 1
  • Buy 6
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $30.00High $54.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 18, 2026
EPS actual vs est.
$-0.93 vs $-0.73
Surprise
-27.40%

PRE news

All PRE news

Prenetics Global peers

Finance sector

Indexes, lists and sector

Prenetics Global stock FAQ

What is Prenetics Global's stock price today?

PRE last traded at $8.80 as of Nov 20, 4:00 PM EST, down 14.65% on the day. Prices are delayed at least 15 minutes.

Does Prenetics Global pay a dividend?

No. Prenetics Global does not currently pay a regular cash dividend.

Who is Prenetics Global's CEO?

Mr. Sheng Wu Yeung is the chief executive officer of Prenetics Global Limited Class A, which has about 98 employees.

Has PRE ever split its stock?

Yes. The most recent PRE stock split was a 1-for-15 split on Nov 14, 2023, one of 2 splits on record.

What is the PRE 52-week high?

The 52-week high for PRE is $27.24 and the 52-week low is $8.69. The stock is currently 67.7% below its high.

Compare PRE